• Mashup Score: 0
    ‘High burden’ of cancer worry in patients with BE, regardless of risk for progression - 1 year(s) ago

    Patients with all stages of Barrett’s esophagus had similar cancer worry, highlighting the need for improved health-related quality of life through education, reassurance and follow-up care, according to data in BMJ Open Gastroenterology.“Health-related quality of life (HRQOL) has become a key domain in assessment of burden of disease,” Elizabeth Ratcliffe, of Wrightington,

    Source: www.healio.com
    Categories: Gastroenterology, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of HealioGastro
      HealioGastro

      Patients with all stages of #Barrettsesophagus had similar #cancer worry, highlighting the need for improved health-related quality of life through #education, reassurance and follow-up care, according to data in@BMJOpen_Gastro @Gut_BMJ https://t.co/CGAq1QiOu7 https://t.co/oKS5PhJl5c

  • Mashup Score: 1
    Random sampling of esophagogastric junction may be unnecessary following BE eradication - 1 year(s) ago

    Follow-up esophagogastric junction sampling for intestinal metaplasia may not be necessary in patients after complete and successful eradication therapy for Barrett’s esophagus, researchers reported. “Although indications and treatment protocol for [endoscopic eradication therapy] are well established, follow-up after successful treatment is less well defined,” C.N. Frederiks,

    Source: www.healio.com
    Categories: Gastroenterology, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of HealioGastro
      HealioGastro

      Random sampling of #esophagogastricjunction may be unnecessary following #Barrettsesophagus eradication #GITwitter #MedTwitter @AGA_CGH https://t.co/8gLvtaOLyz

  • Mashup Score: 0
    Random sampling of esophagogastric junction may be unnecessary following BE eradication - 1 year(s) ago

    Follow-up esophagogastric junction sampling for intestinal metaplasia may not be necessary in patients after complete and successful eradication therapy for Barrett’s esophagus, researchers reported. “Although indications and treatment protocol for [endoscopic eradication therapy] are well established, follow-up after successful treatment is less well defined,” C.N. Frederiks,

    Source: www.healio.com
    Categories: Gastroenterology, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of HealioGastro
      HealioGastro

      Follow-up #esophagogastricjunction sampling for intestinal metaplasia may not be necessary in patients after complete and successful eradication therapy for #Barrettsesophagus @AGA_CGH #GITwitter #MedTwitter https://t.co/8gLvtaOLyz

  • Mashup Score: 2
    Signaling pathway ‘key needle within the haystack’ driving Barrett’s, esophageal cancer - 2 year(s) ago

    Researchers have identified a cell signaling pathway involved in the development of Barrett’s esophagus and esophageal adenocarcinoma, which may lead to possible life-saving therapy for this aggressive cancer.In a study published in Gastroenterology, Kishore Guda, DVM, PhD, associate professor at Case Western Reserve University School of Medicine and Case Comprehensive Cancer Center, and

    Source: www.healio.com
    Categories: Gastroenterology, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of HealioGastro
      HealioGastro

      Researchers have identified a cell signaling pathway involved in the development of #Barrettsesophagus and #esophagealadenocarcinoma, which may lead to possible life-saving therapy for this aggressive #cancer@KishoreGuda #GITwitter #MedTwitter https://t.co/bPO57ikrD5

Load More